Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Atossa Genetics Inc (NQ: ATOS )

1.703 USD -0.057 (-3.23%)
Streaming Delayed Price Updated: 10:08 AM EST, Dec 1, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,386
Open 1.800
Bid (Size) 1.690 (1)
Ask (Size) 1.710 (1)
Prev. Close 1.760
Today's Range 1.670 - 1.800
52wk Range 0.7500 - 5.080
Shares Outstanding 2,651,952
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Atossa Therapeutics Announces Third Quarter 2020 Financial Results and Provides Corporate Update
From GlobeNewswire News Releases
Atossa Therapeutics Announces Preliminary Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
From GlobeNewswire News Releases

Performance

YTD
+7.12%
+7.12%
1 Month
+13.55%
+13.55%
3 Month
-33.21%
-33.21%
6 Month
-30.76%
-30.76%
1 Year
+17.47%
+17.47%

More News

Read More
New Research Points to the People's Liberation Army Hospital in Wuhan, China as the Origin for the Worldwide Coronavirus Pandemic
From PR Newswire
Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID
From GlobeNewswire News Releases
Continuous Testing Market May Set New Growth Story, Key Players – EPAM Systems, HCL Technologies, Mindtree, Atos, Hexaware, and more
Tags Continuous Testing Market trend Continuous Testing Market share HCL Technologies
From X herald
Registration Is Now Open For Atossa Therapeutics’ Tribe Public Webinar Presentation and Q&A Event On October 13, 2020
From GlobeNewswire News Releases
Physician-Scientist Dr. Steven Quay Provides Best-Selling Book, "Stay Safe: A Physician's Guide to Survive Coronavirus," to the White House Upon the News of COVID in the First Family
From PR Newswire
Atossa Therapeutics To Present at the Oppenheimer & Co. Fall Healthcare Life Sciences and MedTech Summit on September 22, 2020
From GlobeNewswire News Releases
Atossa Therapeutics Receives Second Positive Interim Safety Assessment in Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID
From GlobeNewswire News Releases
Physician-Scientist Dr. Steven Quay's "Stay Safe: A Physician's Guide to Survive Coronavirus" Reaches #1 on Five Amazon Bestsellers Lists
From PR Newswire
Physician-Scientist Dr. Steven Quay Shares Back-to-School Tips To Stay Safe and Survive Coronavirus
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.